Long-term Outcome of Treatment of Early Carcinoma of the Lip with Nd:YAG Laser

Tewari, Mallika; Rai, Pramod; Kumar, Mohan; Shukla, Hari S.
April 2008
World Journal of Surgery;Apr2008, Vol. 32 Issue 4, p543
Academic Journal
The aim of this study was to assess the efficacy of the Nd:YAG laser for treating stage I squamous cell carcinoma (SCC) of the lip. The retrospective study was performed in a tertiary care referral hospital in northern India. In January 2007 the records of patients treated by Nd:YAG laser ablation of the lip between January 1997 and January 2000 were reviewed. Patients with a minimum follow-up of 5 years were included. The postoperative integrity of facial nerve, cosmetic and functional results, and disease (recurrence)-free survival (DFS) were assessed. Of the 46 patients included, 42 were disease-free at the end of the first year and 38 after 5 years. Six patients required repeat lasering for a residual or recurrent lesion. Two patients developed regional lymph node metastasis with no infield recurrence and underwent modified radical neck dissection. The 5-year DFS rate was 82.6%. Site of lip involvement (upper or lower), history of tobacco use, or grade of the tumor had no influence on DFS. Cosmetic results were excellent and without any significant complication. Our results support the use of the Nd:YAG laser for treatment of stage I SCC of the lip with minimal morbidity and good DFS.


Related Articles

  • Expression of RFC/SLC19A1 is Associated with Tumor Type in Bladder Cancer Patients. Abdel-Haleem, Alyaa M.; El-Zeiry, Maha I.; Mahran, Laila G.; Abou-Aisha, Khaled; Rady, Mona H.; Rohde, Jan; Mostageer, Marwa; Spahn-Langguth, Hilde // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    Urinary bladder cancer (UBC) ranks ninth in worldwide cancer. In Egypt, the pattern of bladder cancer is unique in that both the transitional and squamous cell types prevail. Despite much research on the topic, it is still difficult to predict tumor progression, optimal therapy and clinical...

  • Epigenetic Disregulation in Oral Cancer. Mascolo, Massimo; Siano, Maria; Ilardi, Gennaro; Russo, Daniela; Merolla, Francesco; De Rosa, Gaetano; Staibano, Stefania // International Journal of Molecular Sciences;Feb2012, Vol. 13 Issue 2, p2331 

    Squamous cell carcinoma of the oral region (OSCC) is one of the most common and highly aggressive malignancies worldwide, despite the fact that significant results have been achieved during the last decades in its detection, prevention and treatment. Although many efforts have been made to...

  • The role of tumor invasion into the mandible of oral squamous cell carcinoma. Mücke, Thomas; Hölzle, Frank; Wagenpfeil, Stefan; Wolff, Klaus-Dietrich; Kesting, Marco // Journal of Cancer Research & Clinical Oncology;Jan2011, Vol. 137 Issue 1, p165 

    Purpose: The aim of this study was to determine the prognostic impact of the extent of bone invasion in patients undergoing mandibulectomy for oral squamous cell carcinoma (OSCC), and to evaluate the relation between clinicopathologic parameters and outcome. Methods: Nine hundred and eighty-two...

  • MicroRNA-193b Enhances Tumor Progression via Down Regulation of Neurofibromin 1. Lenarduzzi, Michelle; Hui, Angela B. Y.; Alajez, Nehad M.; Wei Shi; Williams, Justin; Shijun Yue; O'Sullivan, Brian; Fei-Fei Liu // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Despite improvements in therapeutic approaches for head and neck squamous cell carcinomas (HNSCC), clinical outcome has remained disappointing, with 5-year overall survival rates hovering around 40-50%, underscoring an urgent need to better understand the biological bases of this disease. We...

  • Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients. Liyun Miao; Yongsheng Wang; Suhua Zhu; Minke Shi; Yan Li; Jingjing Ding; Jun Yang; Qing Ye; Hourong Cai; Deping Zhang; Hongbing Iiu; Yong Song // BMC Cancer;2014, Vol. 14 Issue 1, p713 

    Background Although many of the recently approved genomically targeted therapies have improved outcomes for patients in non-small-cell lung cancer (NSCLC) with lung adenocarcinoma, little is known about the genomic alterations that drive lung squamous cell cancer (SCC) and development of...

  • TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma. Hsu, Po-Kuei; Chen, Hsuan-Yu; Yeh, Yi-Chen; Yen, Chueh-Chuan; Wu, Yu-Chung; Hsu, Chung-Ping; Hsu, Wen-Hu; Chou, Teh-Ying // Journal of Gastroenterology;Aug2014, Vol. 49 Issue 8, p1231 

    Background: The molecular and genetic changes underlying esophageal squamous cell carcinoma (ESCC) tumor formation and rapid progression are poorly understood. Using high-throughput data analysis, we examined molecular changes involved in ESCC pathogenesis and investigated their clinical...

  • Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx. Junor, E; Kerr, G; Oniscu, A; Campbell, S; Kouzeli, I; Gourley, C; Cuschieri, K // British Journal of Cancer;1/17/2012, Vol. 106 Issue 2, p358 

    Background:To determine (a) the cause of an improvement in survival from oropharyngeal squamous cell carcinoma (OSCC) in South East Scotland and (b) whether this improvement was human papillomavirus (HPV) and p16 subtype-dependent.Methods:Clinicopathological characteristics and outcome data for...

  • TBL1XR1 promotes lymphangiogenesis and lymphatic metastasis in esophageal squamous cell carcinoma. Liping Liu; Chuyong Lin; Weijiang Liang; Shu Wu; Aibin Liu; Jueheng Wu; Xin Zhang; Pengli Ren; Mengfeng Li; Libing Song // Gut;Jan2015, Vol. 64 Issue 1, p26 

    Objective Transducin (ß)-like 1 X-linked receptor 1 (TBL1XR1) plays an important role in controlling the precisely regulated switch between gene repression and gene activation in transcriptional regulation. We investigated its biological function and clinical significance in esophageal...

  • Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis. Yongmei Song; Chunling Zhao; Lijia Dong; Ming Fu; Liyan Xue; Zhen Huang; Tong Tong; Zhuan Zhou; Amei Chen; Zhihua Yang; Ning Lu; Qimin Zhan // Carcinogenesis;Feb2008, Vol. 29 Issue 2, p307 

    Cyclin B1, a key component in the control of cell cycle progression from G2 to M phase, has been implicated in tumorigenesis and the development of malignancy. However, the underlying mechanism by which cyclin B1 acts as an important oncogenic molecule remains largely unknown. Here we show that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics